References
- Albrink M J, Man E B. Serum triglycerides in coronary artery disease. Arch Intern Med 1959; 103: 4–8
- Albrink M J, Meigs J W. Interrelationships between skin-fold thickness, serum lipids and blood sugar in normal man. Am J Clin Nutr 1964; 15: 255–61
- Kannel W B, Castelli W P, Gordon T, MacMara P M. Serum cholesterol, lipoproteins and risk of coronary heart disease. Ann Intern Med 1971; 74: 1–12
- Böttiger L E, Carlson L A. Risk factors for ischaemic vascular death for men in the Stockholm Prospective Study. Atherosclerosis 1980; 36: 389–408
- Hulley S B, Rosenman R H, Bawol R J, Brand R J. Epidemiology as a guide to clinical decisions. The association between rriglyceride and coronary heart disease. N Engl J Med 1980; 302: 1383–9
- Carlson L A, Rössner S. A methodological study of an intravenous fat tolerance test with Intralipidr` emulsion. Scand J Gin Lab Invest 1972; 29: 271–80
- Rössner S, Boberg J, Carlson L A, Freyschuss U, Lassers B W. Comparison between fractional turnover rate of endogenous plasma triglycerides and of Intralipidr` (intravenous fat tolerance test) in man. Eur J Clin Invest 1974; 4: 109–14
- Carlsson L A. Studies on the fat emulsion Intralipidr` triglyceride I. Association of proteins to Intralipid triglyceride particles (ITP). Scand J Clin Lab Invest 1980; 40: 139–44
- Zilversmit D B. A proposal linking atherosclerosis to the interaction of endothelial lipoprotein lipase with triglyceride-rich lipoproteins. Circ Res 1973; 33: 633–8
- Tollin C, Ericsson M, Johnson O, Jacobsson K A, Backman C, Billström Å, Ostermart G. Decreased removal of triglycerides: a mechanism for the hypertriglyceridemia in male patients with coronary artery disease. Int J Cardiol 1984; 5: 185–92
- Carlson L A, Hallberg D. Studies of the elimination of exogenous lipids from the blood stream. The kinetics of the elimination of a fat emulsion and of chylomicrons in the dog after single injection. Acta Physiol Scand 1963; 59: 52–61
- Boberg J, Carlson L A, Hallberg D. Application of a new intravenous fat tolerance test in the study of hypertriglyceridemia in man. J Atheroscl Res 1969; 9: 159–69
- Carlson K. Lipoprotein fractionation. J Clin Path 1973; 26(Suppl 5)32–7
- Wahlefled A W. Triglyceride bestimmung nach enzymatischer verseifung. Methods of Enzymatic Analyses, 2nd edition, H K Bergmeier. Academic Press, New York and London 1974; 1831–5
- Borner K, Klose S. Enzymatische bestimmung des gesamtcholesterins mit dem greiner selective analyzer (GSA-II). J Clin Chem Clin Biochem 1977; 15: 121–30
- Snedecor G W, Cochran W G. Statistical Methods, 6th edition. Iowa State University Press, Ames, IowaUSA 1972
- Carlson L A, Lindstedt S. The Stockholm Prospective Study. Part I (the initial values for plasma lipids). Acta Med Scand 1969, Suppl 493: 1–135
- Carlson L A, Ericsson M. Quantitative and qualitative serum lipoprotein analysis. Part 1. Study in healthy men and women. Atherosclerosis 1975; 21: 417–33
- Olsson A G, Walldius G, Rössner S, Callner C, Kaijser L. Studies on serum lipoproteins and lipid metabolism. Acta Med Scand 1980, Suppl 637: 1–47
- Nikkilä E A, Kekki M. Polymorphism of plasma triglyceride kinetics in normal human adult subjects. Acta Med Scand 1971; 190: 49–59
- Vedin J A, Vilhelmson C E, Bolander A M, Werkö L. Mortality trends in Sweden with special reference to cardiovascular causes of death. Acta Med Scand 1971, Suppl 515: 1–76
- Grundy S M. Hyperlipoproteinaemia: metabolic basis and rationale for therapy. Am J Cardiol 1984; 54: 20C–26C